SC Labs And ACT Laboratories Launch Trust In Testing Certification To Set A Higher Standard For Cannabis Testing

ACT Laboratories and SC Labs announced the Trust In Testing Certification, a set of enhanced national standards for cannabis testing. SC Labs and ACT Laboratories are jointly taking a stand for consumer safety by outlining the most stringent lab quality requirements to ensure brands and consumers can trust their lab testing data. According to the companies the initiative will help cannabis operators unify their testing protocols across their multi-state footprints, enable brands to build consumer loyalty, maintain investor and customer confidence, and, ultimately, provide safer products to the growing cannabis market.

"ACT Laboratories believes that consumers have the right to know what is in their cannabis products. This is an emerging problem: The risk of testing result inaccuracy is greater than ever for cannabis brands hoping to deliver safe and reliable products to their customers as allegations of testing fraud are rampant across the country," stated Michael Drozd, CEO of ACT Laboratories. "Poor quality testing data can adversely impact brand reputation, resulting in loss of business, hefty fines, legal action or, in some cases, licenses being revoked. And worst of all, it erodes customer confidence, has a negative financial impact, and presents a potential consumer safety risk."

Cannabis brands that want to demonstrate their commitment to quality and providing accurate and reliable data may use the Trust in Testing seal on products that have been tested by a Trust in Testing Certified Lab. Similar to the "Certified Organic" seal commonly seen in the produce aisle, the Trust in Testing seal provides a simple way for cannabis consumers to feel confident that the products they are purchasing and consuming have successfully passed all potency and contaminant testing requirements.

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Louis Reed on Unsplash